• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

呼吸道合胞病毒感染患者鼻腔吸出物中呼吸道合胞病毒的稳定性

Stability of Respiratory Syncytial Virus in Nasal Aspirate From Patients Infected With RSV.

作者信息

Yamamoto Atsuko, Hayasaki-Kajiwara Yoko, Baba Takamichi, Okaga Saori, Kakui Mayumi, Shishido Takao

机构信息

Laboratory for Drug Discovery and Disease Research, Shionogi & Co, Ltd, Osaka, Japan.

Biostatistics Center, Shionogi & Co, Ltd, Osaka, Japan.

出版信息

Influenza Other Respir Viruses. 2024 Dec;18(12):e70058. doi: 10.1111/irv.70058.

DOI:10.1111/irv.70058
PMID:39682057
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11649581/
Abstract

BACKGROUND

Evaluation of infectious virus titer is a challenge for respiratory syncytial virus (RSV) clinical trials because of the labile nature of RSV and rapid loss of infectivity without proper specimen handling. However, there has been no rigorous investigation into RSV stability in clinical specimens.

METHODS

RSV stability was investigated by evaluating virus titers and defined as titer variation from baseline within three standard deviations of our titration assay. RSV stability in viral transport medium (VTM) at 4°C and the effect of freezing method on stability were evaluated using RSV-A2 stock. RSV stability in nasal aspirates collected in VTM at 4°C was estimated by regression analysis of virus titers measured at several time points. Stability of these specimens stored at -80°C for 10-15 months after freezing by the method, which maintained RSV-A2 stability, was also assessed.

RESULTS

Three standard deviations were calculated from our titration assay as 0.97 log 50% tissue culture infectious dose (TCID/mL), and RSV stability was defined as variation of virus titer from baseline within 1.0 logTCID/mL. RSV-A2 in VTM at 4°C was stable for at least 120 h. Freezing at -80°C negatively affected virus stability, whereas freezing in liquid nitrogen or a dry ice-ethanol bath did not. RSV in nasal aspirates was stable for 2 days at 4°C and for 10-15 months at -80°C after snap freezing.

CONCLUSIONS

RSV in nasal aspirates in VTM was estimated to be stable for 2 days at 4°C and for approximately 1 year at -80°C.

摘要

背景

由于呼吸道合胞病毒(RSV)性质不稳定,且在标本处理不当的情况下感染力会迅速丧失,因此评估传染性病毒滴度对RSV临床试验来说是一项挑战。然而,尚未对临床标本中RSV的稳定性进行严格研究。

方法

通过评估病毒滴度来研究RSV的稳定性,并将其定义为滴定测定三个标准差范围内相对于基线的滴度变化。使用RSV-A2储备液评估RSV在4°C病毒运输培养基(VTM)中的稳定性以及冷冻方法对稳定性的影响。通过对在多个时间点测得的病毒滴度进行回归分析,估算在4°C下收集于VTM中的鼻吸出物中RSV的稳定性。还评估了采用能维持RSV-A2稳定性的方法冷冻后,这些标本在-80°C下储存10 - 15个月的稳定性。

结果

根据我们的滴定测定,计算出三个标准差为0.97 log 50%组织培养感染剂量(TCID/mL),RSV稳定性定义为病毒滴度相对于基线的变化在1.0 logTCID/mL以内。4°C下VTM中的RSV-A2至少120小时内稳定。-80°C冷冻对病毒稳定性有负面影响,而在液氮或干冰 - 乙醇浴中冷冻则没有。鼻吸出物中的RSV在4°C下2天内稳定,速冻后在-80°C下10 - 15个月内稳定。

结论

VTM中鼻吸出物内的RSV估计在4°C下2天内稳定,在-80°C下约1年内稳定。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9d66/11649581/82d17dfea303/IRV-18-e70058-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9d66/11649581/bc5faea26bed/IRV-18-e70058-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9d66/11649581/82d17dfea303/IRV-18-e70058-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9d66/11649581/bc5faea26bed/IRV-18-e70058-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9d66/11649581/82d17dfea303/IRV-18-e70058-g002.jpg

相似文献

1
Stability of Respiratory Syncytial Virus in Nasal Aspirate From Patients Infected With RSV.呼吸道合胞病毒感染患者鼻腔吸出物中呼吸道合胞病毒的稳定性
Influenza Other Respir Viruses. 2024 Dec;18(12):e70058. doi: 10.1111/irv.70058.
2
Viral load in hospitalized infants with respiratory syncytial virus bronchiolitis: a three-way comparative analysis.住院婴儿呼吸道合胞病毒毛细支气管炎病毒载量:三项比较分析。
Eur J Pediatr. 2024 Aug;183(8):3471-3478. doi: 10.1007/s00431-024-05614-3. Epub 2024 May 23.
3
Proof of stability of an RSV Controlled Human Infection Model challenge agent.证明 RSV 受控人体感染模型挑战剂的稳定性。
Virol J. 2024 May 15;21(1):112. doi: 10.1186/s12985-024-02386-y.
4
Sucrose stabilization of Respiratory Syncytial Virus (RSV) during nebulization and experimental infection.雾化和实验性感染期间呼吸道合胞病毒(RSV)的蔗糖稳定作用
BMC Res Notes. 2014 Mar 18;7:158. doi: 10.1186/1756-0500-7-158.
5
Live Respiratory Syncytial Virus (RSV) Vaccine Candidate Containing Stabilized Temperature-Sensitivity Mutations Is Highly Attenuated in RSV-Seronegative Infants and Children.含稳定温度敏感性突变的活呼吸道合胞病毒(RSV)疫苗候选物在 RSV 血清阴性婴儿和儿童中高度减毒。
J Infect Dis. 2018 Apr 11;217(9):1338-1346. doi: 10.1093/infdis/jiy066.
6
Use of rapid human respiratory syncytial virus strip tests for detection of bovine respiratory syncytial virus in experimentally vaccinated calves.使用快速人类呼吸道合胞病毒试纸条检测实验性接种疫苗犊牛中的牛呼吸道合胞病毒。
Pol J Vet Sci. 2012;15(4):629-34. doi: 10.2478/v10181-012-0099-y.
7
[Usefulness of a Newly Developed Immunochromatographic Assay Kit for the Detection of Respiratory Syncytial Virus].[一种新开发的用于检测呼吸道合胞病毒的免疫层析检测试剂盒的实用性]
Kansenshogaku Zasshi. 2015 Sep;89(5):574-8. doi: 10.11150/kansenshogakuzasshi.89.574.
8
Variation in Thermal Stability among Respiratory Syncytial Virus Clinical Isolates under Non-Freezing Conditions.呼吸道合胞病毒临床分离株在非冻结条件下的热稳定性变化。
Viruses. 2022 Mar 25;14(4):679. doi: 10.3390/v14040679.
9
Multicenter Clinical Evaluation of the Alere i Respiratory Syncytial Virus Isothermal Nucleic Acid Amplification Assay.多中心临床评价爱理尔呼吸道合胞病毒等温核酸扩增检测试剂盒。
J Clin Microbiol. 2018 Feb 22;56(3). doi: 10.1128/JCM.01777-17. Print 2018 Mar.
10
Virus-Specific Antibody, Viral Load, and Disease Severity in Respiratory Syncytial Virus Infection.呼吸道合胞病毒感染中的病毒特异性抗体、病毒载量和疾病严重程度。
J Infect Dis. 2018 Jun 20;218(2):208-217. doi: 10.1093/infdis/jiy106.

本文引用的文献

1
Comparing molnupiravir and nirmatrelvir/ritonavir efficacy and the effects on SARS-CoV-2 transmission in animal models.比较莫努匹韦和奈玛特韦/利托那韦在动物模型中的疗效及对 SARS-CoV-2 传播的影响。
Nat Commun. 2023 Aug 7;14(1):4731. doi: 10.1038/s41467-023-40556-8.
2
Efficacy and Safety of Ensitrelvir in Patients With Mild-to-Moderate Coronavirus Disease 2019: The Phase 2b Part of a Randomized, Placebo-Controlled, Phase 2/3 Study.恩赛特韦在轻至中度 2019 冠状病毒病患者中的疗效和安全性:一项随机、安慰剂对照、2/3 期研究的 2b 期部分。
Clin Infect Dis. 2023 Apr 17;76(8):1403-1411. doi: 10.1093/cid/ciac933.
3
Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in children younger than 5 years in 2019: a systematic analysis.
2019 年全球、区域和国家因呼吸道合胞病毒导致 5 岁以下儿童急性下呼吸道感染的疾病负担估计:系统分析。
Lancet. 2022 May 28;399(10340):2047-2064. doi: 10.1016/S0140-6736(22)00478-0. Epub 2022 May 19.
4
Variation in Thermal Stability among Respiratory Syncytial Virus Clinical Isolates under Non-Freezing Conditions.呼吸道合胞病毒临床分离株在非冻结条件下的热稳定性变化。
Viruses. 2022 Mar 25;14(4):679. doi: 10.3390/v14040679.
5
Mucins Inhibit Coronavirus Infection in a Glycan-Dependent Manner.黏蛋白以聚糖依赖的方式抑制冠状病毒感染。
ACS Cent Sci. 2022 Mar 23;8(3):351-360. doi: 10.1021/acscentsci.1c01369. Epub 2022 Feb 14.
6
Serine proteases in neutrophil extracellular traps exhibit anti-Respiratory Syncytial Virus activity.中性粒细胞胞外诱捕网中的丝氨酸蛋白酶具有抗呼吸道合胞病毒活性。
Int Immunopharmacol. 2022 May;106:108573. doi: 10.1016/j.intimp.2022.108573. Epub 2022 Feb 16.
7
Abnormal Airway Mucus Secretion Induced by Virus Infection.病毒感染导致的气道黏液异常分泌。
Front Immunol. 2021 Sep 28;12:701443. doi: 10.3389/fimmu.2021.701443. eCollection 2021.
8
Transmissibility and transmission of respiratory viruses.呼吸道病毒的传播力和传播。
Nat Rev Microbiol. 2021 Aug;19(8):528-545. doi: 10.1038/s41579-021-00535-6. Epub 2021 Mar 22.
9
Current State of Respiratory Syncytial Virus Disease and Management.呼吸道合胞病毒疾病的现状与管理
Infect Dis Ther. 2021 Mar;10(Suppl 1):5-16. doi: 10.1007/s40121-020-00387-2. Epub 2021 Mar 3.
10
Defensive Properties of Mucin Glycoproteins during Respiratory Infections-Relevance for SARS-CoV-2.黏液糖蛋白在呼吸道感染中的防御特性——与 SARS-CoV-2 的相关性。
mBio. 2020 Nov 12;11(6):e02374-20. doi: 10.1128/mBio.02374-20.